CJC-1295 (No DAC) + Ipamorelin

CJC-1295 (No DAC) + Ipamorelin is a research peptide combination consisting of a growth hormone-releasing hormone (GHRH) analog and a selective growth hormone secretagogue receptor (GHSR-1a) agonist. CJC-1295 (No DAC) is designed to interact with GHRH receptors in the anterior pituitary, while ipamorelin is designed to bind to ghrelin (GHSR-1a) receptors involved in growth hormone signaling. This combination has been the subject of scientific investigation to evaluate the interaction of these complementary signaling pathways, along with their receptor activity, pharmacokinetic characteristics, endocrine signaling, and overall mechanism of action. Ongoing laboratory and clinical research continues to examine the biological properties and physiological responses associated with this peptide combination under controlled study conditions.